Colinz Laboratories Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Padam Dugar & Others, was filed 27 May 2026.
Colinz Laboratories: what insiders have been doing
Every trade that managers of Colinz Laboratories disclose to SEBI (PIT + SAST) is tracked on this page. In the past year (9 November 2025 to 9 November 2026), 7 filings came from 7 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Over the last twelve months, not one insider purchase of Colinz Laboratories stock was filed. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade.
Across the 1,985 companies tracked on its exchange, the median is 4 filings; at 7 filings, this issuer sits above that mark. Since 2026, the database holds 5 purchases and 2 sales by insiders of the company.
Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +42.4%Entry ₹50.93 · Close at T+90 ₹72.51
- +44.4%Entry ₹50.93 · Close at T+90 ₹73.55
- +44.4%Entry ₹50.93 · Close at T+90 ₹73.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 378,000 shares-Off MarketSEBI:f2ba1be5b3037e49c1c600d69bd06ee62c432d15Canonical exit: 25 Aug 2026 (T+90)
- 378,000 shares-Off MarketSEBI:5fabc80623fe208c43c88498283653d09a2f66a1
- 11,000 shares@ ₹50.00100.0% of flowEquity SharesOff MarketSEBI:37db1ce5f8f49b94e49fa8f494e2e984ec7cb2baCanonical exit: 24 Aug 2026 (T+90)
- 378,000 shares@ ₹50.00100.0% of flowEquity SharesOff MarketSEBI:30aa174d36d72ae9a6e1558823e2a49832863100
- 316,000 shares@ ₹50.00100.0% of flowEquity SharesOff MarketSEBI:97534609ad181eee4de1a4737165bdee04f65118Canonical exit: 24 Aug 2026 (T+90)
- 40,000 shares@ ₹50.00100.0% of flowEquity SharesOff MarketSEBI:e94c0b6740ade6f03c9071cefc6db29e5a5df6acCanonical exit: 24 Aug 2026 (T+90)
- 11,000 shares@ ₹50.00100.0% of flowEquity SharesOff MarketSEBI:cd47d7cfe61d5d1a882619399751b1454b164bdfCanonical exit: 24 Aug 2026 (T+90)
7 of 7 declarations
About Colinz Laboratories
Colinz Laboratories is a company listed on the XBOM, specializing in the development and manufacturing of pharmaceutical products. It focuses on innovation and research to enhance patient health.